Literature DB >> 20008833

The nutrigenetics of hyperhomocysteinemia: quantitative proteomics reveals differences in the methionine cycle enzymes of gene-induced versus diet-induced hyperhomocysteinemia.

Patricia M DiBello1, Sanjana Dayal, Suma Kaveti, Dongmei Zhang, Michael Kinter, Steven R Lentz, Donald W Jacobsen.   

Abstract

Hyperhomocysteinemia has long been associated with atherosclerosis and thrombosis and is an independent risk factor for cardiovascular disease. Its causes include both genetic and environmental factors. Although homocysteine is produced in every cell as an intermediate of the methionine cycle, the liver contributes the major portion found in circulation, and fatty liver is a common finding in homocystinuric patients. To understand the spectrum of proteins and associated pathways affected by hyperhomocysteinemia, we analyzed the mouse liver proteome of gene-induced (cystathionine beta-synthase (CBS)) and diet-induced (high methionine) hyperhomocysteinemic mice using two-dimensional difference gel electrophoresis and Ingenuity Pathway Analysis. Nine proteins were identified whose expression was significantly changed by 2-fold (p < or = 0.05) as a result of genotype, 27 proteins were changed as a result of diet, and 14 proteins were changed in response to genotype and diet. Importantly, three enzymes of the methionine cycle were up-regulated. S-Adenosylhomocysteine hydrolase increased in response to genotype and/or diet, whereas glycine N-methyltransferase and betaine-homocysteine methyltransferase only increased in response to diet. The antioxidant proteins peroxiredoxins 1 and 2 increased in wild-type mice fed the high methionine diet but not in the CBS mutants, suggesting a dysregulation in the antioxidant capacity of those animals. Furthermore, thioredoxin 1 decreased in both wild-type and CBS mutants on the diet but not in the mutants fed a control diet. Several urea cycle proteins increased in both diet groups; however, arginase 1 decreased in the CBS(+/-) mice fed the control diet. Pathway analysis identified the retinoid X receptor signaling pathway as the top ranked network associated with the CBS(+/-) genotype, whereas xenobiotic metabolism and the NRF2-mediated oxidative stress response were associated with the high methionine diet. Our results show that hyperhomocysteinemia, whether caused by a genetic mutation or diet, alters the abundance of several liver proteins involved in homocysteine/methionine metabolism, the urea cycle, and antioxidant defense.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20008833      PMCID: PMC2849704          DOI: 10.1074/mcp.M900406-MCP200

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  74 in total

1.  STUDIES IN METHIONINE AND SULFUR METABOLISM. I. THE FATE OF INTRAVENOUSLY ADMINISTERED METHIONINE, IN NORMAL INDIVIDUALS AND IN PATIENTS WITH LIVER DAMAGE.

Authors:  L W Kinsell; H A Harper; H C Barton; M E Hutchin; J R Hess
Journal:  J Clin Invest       Date:  1948-09       Impact factor: 14.808

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Characterization of homocysteine metabolism in the rat liver.

Authors:  L M Stead; M E Brosnan; J T Brosnan
Journal:  Biochem J       Date:  2000-09-15       Impact factor: 3.857

4.  Oxidative stress, metabolism of ethanol and alcohol-related diseases.

Authors:  T Zima; L Fialová; O Mestek; M Janebová; J Crkovská; I Malbohan; S Stípek; L Mikulíková; P Popov
Journal:  J Biomed Sci       Date:  2001 Jan-Feb       Impact factor: 8.410

5.  Beneficial effects of inducible nitric oxide synthase inhibitor on reperfusion injury in the pig liver.

Authors:  M Isobe; T Katsuramaki; K Hirata; H Kimura; M Nagayama; T Matsuno
Journal:  Transplantation       Date:  1999-09-27       Impact factor: 4.939

6.  Assessment of endoplasmic reticulum glutathione redox status is confounded by extensive ex vivo oxidation.

Authors:  Brian M Dixon; Shi-Hua D Heath; Robert Kim; Jung H Suh; Tory M Hagen
Journal:  Antioxid Redox Signal       Date:  2008-05       Impact factor: 8.401

7.  Determination of plasma homocysteine by high-performance liquid chromatography with fluorescence detection.

Authors:  D W Jacobsen; V J Gatautis; R Green
Journal:  Anal Biochem       Date:  1989-04       Impact factor: 3.365

8.  Pancreatic one-carbon metabolism in early folate deficiency in rats.

Authors:  M Balaghi; D W Horne; S C Woodward; C Wagner
Journal:  Am J Clin Nutr       Date:  1993-08       Impact factor: 7.045

9.  Quantitative study in vivo of methionine cycle in humans using [methyl-2H3]- and [1-13C]methionine.

Authors:  K J Storch; D A Wagner; J F Burke; V R Young
Journal:  Am J Physiol       Date:  1988-09

10.  Quantifying the global cellular thiol-disulfide status.

Authors:  Rosa E Hansen; Doris Roth; Jakob R Winther
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-02       Impact factor: 11.205

View more
  4 in total

1.  Hyperhomocysteinemia during aortic aneurysm, a plausible role of epigenetics.

Authors:  Nithya Narayanan; Neetu Tyagi; Amy Shah; Sebastian Pagni; Suresh C Tyagi
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2013-03-08

2.  Homocysteine thiolactone and N-homocysteinylated protein induce pro-atherogenic changes in gene expression in human vascular endothelial cells.

Authors:  Dorota Gurda; Luiza Handschuh; Weronika Kotkowiak; Hieronim Jakubowski
Journal:  Amino Acids       Date:  2015-03-24       Impact factor: 3.520

3.  A(a)LS: Ammonia-induced amyotrophic lateral sclerosis.

Authors:  Bhavin Parekh
Journal:  F1000Res       Date:  2015-05-14

4.  Effects of dietary salt on gene and protein expression in brain tissue of a model of sporadic small vessel disease.

Authors:  Emma L Bailey; Martin W McBride; John D McClure; Wendy Beattie; Delyth Graham; Anna F Dominiczak; Colin Smith; Joanna M Wardlaw
Journal:  Clin Sci (Lond)       Date:  2018-06-26       Impact factor: 6.124

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.